Adenoid Cystic Carcinoma
📧 Sign up to get email alerts when something new happens for Adenoid Cystic Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Results: A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) [Phase 2]
Phase 2 trial evaluating rivoceranib in recurrent or metastatic adenoid cystic carcinoma has been terminated; results posted.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer [Phase 1]
A Phase 1 clinical trial evaluating AL101 for Notch-activated Adenoid Cystic Carcinoma (including metastatic disease) is currently active bu…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Agnostic Therapy in Rare Solid Tumors [Phase 2]
A Phase 2 trial of an agnostic therapy for multiple rare solid tumors is currently recruiting. The study lists a broad set of tumor types ac…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of XMT-1660 in Participants With Solid Tumors [Phase 1]
Phase 1 study of XMT-1660 in participants with solid tumors is currently recruiting. The trial lists indications including triple-negative b…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors [Phase 2]
This Phase 2 trial update describes testing nivolumab plus ipilimumab in patients with a broad set of rare tumors and notes the study status…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Recurrent Sinonasal Adenoid Cystic Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating Becotatug Vedotin (MRG003) with Epirubicin as neoadjuvant therapy for EGFR-positive, unresectable recurr…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP) [Phase 2]
Phase 2 clinical trial update for Sacituzumab Tirumotecan in recurrent or metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinom…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma [Phase 2]
This clinical trial update describes a Phase 2 study of enfortumab vedotin in patients with adenoid cystic carcinoma that is currently recru…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I) [Phase 2]
Phase II clinical trial update for Puxitatug Samrotecan (AZD8205) in advanced, recurrent or metastatic Aggressive Adenoid Cystic Carcinoma S…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma [Phase 1, Phase 2]
Remix Therapeutics is conducting a Phase 1/2 trial of REM-422 in patients with recurrent, metastatic, or unresectable adenoid cystic carcino…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer [Phase 2]
This clinical trial update reports the Phase 2 study of pemetrexed plus pembrolizumab for recurrent/metastatic salivary gland carcinoma, wit…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: 177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma [Phase 2]
A Phase 2 trial of 177Lu-PNT2002 (177Lu-PSMA radiopharmaceutical) for PSMA-positive Adenoid Cystic Carcinoma was terminated. The update does…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study [Phase 2]
A Phase 2 study evaluating epirubicin-based interventional chemotherapy for sinonasal adenoid cystic carcinoma (SNACC) is currently recruiti…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma [Phase 1, Phase 2]
Clinical trial update for VMD-928 as a monotherapy and in combination with pembrolizumab to treat TrkA overexpression-driven solid tumors or…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC) [Phase 1]
A Phase 1 study evaluating the safety and efficacy of RGT-61159 in adults with relapsed or refractory Adenoid Cystic Carcinoma or Colorectal…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers [Phase 2]
Update on a Phase 2 trial of lenvatinib plus pembrolizumab in advanced adenoid cystic carcinoma and other salivary gland cancers. The study …
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial [NA]
The SOLAR trial is evaluating stereotactic body radiotherapy for early treatment of oligometastatic adenoid cystic carcinoma and is currentl…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit [Phase 1]
Phase 1 study evaluating NN3201, a c-Kit targeted antibody-drug conjugate, in advanced and/or metastatic solid tumors expressing c-Kit; curr…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating Ga-68 PSMA-11 PET/CT as a diagnostic scan to detect therapy response in metastatic adenoid cystic carcin…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma [Phase 2]
Phase 2 trial evaluating regorafenib in patients with progressive, recurrent, or metastatic adenoid cystic carcinoma has completed, with res…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE
Describes a descriptive cohort of French patients treated with carbon ion therapy for various cancers, reported outside a PHRC-ETOILE progra…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers [Phase 2]
This entry reports a Phase 2 clinical trial of the investigational agent Ivonescimab for advanced, metastatic salivary gland cancers that is…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating CB-103 in combination with either lenvatinib or abemaciclib for Adenoid Cystic Carcinoma, inc…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma [Phase 2]
Phase 2 clinical trial investigating lenvatinib for Adenoid cystic carcinoma. The study status is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma [Phase 2]
Phase 2 trial evaluating 9-ING-41 in combination with carboplatin for salivary gland cancer, including adenoid cystic carcinoma; the study i…